Philip Mazzara Sells 796 Shares of Astera Labs (NASDAQ:ALAB) Stock

May 27, 2026 by InsiderTrades.com

Key Points

Astera Labs General Counsel Philip Mazzara sold 796 shares on May 21 at an average price of $291.03, worth about $231,660. After the sale, he still owned 103,343 shares valued at roughly $30.1 million.
The company’s recent performance has been strong, with the stock up 3.9% and trading near its 12-month high of $321.99. Astera Labs also beat quarterly earnings and revenue estimates, with revenue up 93.5% year over year.
Analysts remain broadly constructive but mixed, with multiple firms raising price targets while one recent downgrade came from Northland Securities. Overall, the stock carries a consensus “Moderate Buy” rating and an average price target of $233.75.

Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report) General Counsel Philip Mazzara sold 796 shares of the firm's stock in a transaction that occurred on Thursday, May 21st. The shares were sold at an average price of $291.03, for a total value of $231,659.88. Following the completion of the sale, the general counsel directly owned 103,343 shares of the company's stock, valued at approximately $30,075,913.29. The trade was a 0.76% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

5 Stocks Positioned to Benefit From the AI Inference Boom

Philip Mazzara also recently made the following trade(s):

On Monday, May 18th, Philip Mazzara sold 14,076 shares of Astera Labs stock. The shares were sold at an average price of $231.78, for a total value of $3,262,535.28.
On Wednesday, April 1st, Philip Mazzara sold 10,000 shares of Astera Labs stock. The shares were sold at an average price of $107.77, for a total value of $1,077,700.00.
On Monday, March 2nd, Philip Mazzara sold 10,000 shares of Astera Labs stock. The shares were sold at an average price of $117.47, for a total value of $1,174,700.00.

Astera Labs Stock Up 3.9%

ALAB opened at $318.72 on Wednesday. The stock has a market cap of $54.63 billion, a price-to-earnings ratio of 215.35, a PEG ratio of 4.06 and a beta of 3.35. The business has a 50 day moving average of $178.09 and a 200-day moving average of $161.43. Astera Labs, Inc. has a 12-month low of $84.78 and a 12-month high of $321.99.

Nuts and Bolts AI Play Gains Momentum: Astera Labs Targets Raised

Astera Labs (NASDAQ:ALAB - Get Free Report) last released its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, topping the consensus estimate of $0.54 by $0.07. The business had revenue of $308.36 million during the quarter, compared to analysts' expectations of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The firm's revenue for the quarter was up 93.5% compared to the same quarter last year. During the same period last year, the firm posted $0.33 EPS. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, analysts expect that Astera Labs, Inc. will post 1.84 earnings per share for the current year.

Hedge Funds Weigh In On Astera Labs

A number of hedge funds have recently added to or reduced their stakes in the stock. Glenmede Trust Co. NA increased its stake in Astera Labs by 2.7% during the 1st quarter. Glenmede Trust Co. NA now owns 1,909 shares of the company's stock worth $209,000 after acquiring an additional 51 shares during the period. Lido Advisors LLC increased its stake in Astera Labs by 0.5% during the 4th quarter. Lido Advisors LLC now owns 12,297 shares of the company's stock worth $2,046,000 after acquiring an additional 57 shares during the period. Perigon Wealth Management LLC increased its stake in Astera Labs by 6.2% during the 4th quarter. Perigon Wealth Management LLC now owns 1,252 shares of the company's stock worth $208,000 after acquiring an additional 73 shares during the period. Clearstead Advisors LLC increased its stake in Astera Labs by 13.6% during the 3rd quarter. Clearstead Advisors LLC now owns 636 shares of the company's stock worth $125,000 after acquiring an additional 76 shares during the period. Finally, Sound Income Strategies LLC increased its stake in Astera Labs by 9.2% during the 4th quarter. Sound Income Strategies LLC now owns 902 shares of the company's stock worth $164,000 after acquiring an additional 76 shares during the period. Institutional investors own 60.47% of the company's stock.

Key Stories Impacting Astera Labs

5 AI Infrastructure Stocks Smart Money Is Buying Before the Next Surge

Here are the key news stories impacting Astera Labs this week:

Positive Sentiment: Astera Labs announced it will host press conferences, live demos, and technical talks at Computex 2026, where it plans to showcase its AI infrastructure connectivity portfolio, including the Scorpio X-Series 320 Lane Smart Fabric Switch, optical connectivity, and COSMOS-enabled validation tools. The event should boost visibility with analysts, customers, and ecosystem partners. Article Title
Positive Sentiment: Recent coverage highlighted ALAB’s strong stock momentum and cited bullish analyst views, which appears to be reinforcing investor enthusiasm for the company’s AI networking and semiconductor growth story. Article Title
Neutral Sentiment: Astera Labs was downgraded by Northland Securities from outperform to market perform, which could temper some of the recent optimism but does not by itself indicate a major deterioration in the business outlook.
Negative Sentiment: Insider selling continues to be notable, including a large COO sale under a 10b5-1 plan and a smaller sale by the general counsel. While preplanned, heavy insider selling can weigh on sentiment because it may suggest executives are taking profits after the stock’s sharp run-up.

Analysts Set New Price Targets

Several analysts recently weighed in on ALAB shares. Roth Mkm reissued a "buy" rating and set a $275.00 price target on shares of Astera Labs in a report on Wednesday, May 6th. Susquehanna lifted their price target on Astera Labs from $155.00 to $230.00 and gave the stock a "neutral" rating in a report on Wednesday, May 6th. Royal Bank Of Canada lifted their price target on Astera Labs from $250.00 to $270.00 and gave the stock an "outperform" rating in a report on Wednesday, May 6th. Needham & Company LLC lifted their price target on Astera Labs from $220.00 to $260.00 and gave the stock a "buy" rating in a report on Wednesday, May 6th. Finally, JPMorgan Chase & Co. raised their price objective on Astera Labs from $205.00 to $280.00 and gave the stock an "overweight" rating in a research note on Wednesday, May 6th. Twelve investment analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the stock. According to data from MarketBeat.com, Astera Labs currently has an average rating of "Moderate Buy" and a consensus price target of $233.75.

Check Out Our Latest Stock Analysis on Astera Labs

Astera Labs Company Profile

(Get Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company's product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.